Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery

Adult Blood Glucose Male Adolescent Individuality Multicenter Studies as Topic/statistics & numerical data Young Adult 03 medical and health sciences Blood Glucose/drug effects Insulin Infusion Systems 0302 clinical medicine Humans Hypoglycemic Agents Insulin Multicenter Studies as Topic Child Blood Glucose Self-Monitoring/instrumentation Aged Randomized Controlled Trials as Topic Retrospective Studies Cross-Over Studies Dose-Response Relationship, Drug Randomized Controlled Trials as Topic/statistics & numerical data Blood Glucose Self-Monitoring Age Factors Infant Diabetes Mellitus, Type 1/blood Middle Aged Hypoglycemic Agents/administration & dosage 3. Good health Diabetes Mellitus, Type 1 Child, Preschool Female Insulin/administration & dosage
DOI: 10.2337/dc18-2625 Publication Date: 2019-06-14T19:52:11Z
AUTHORS (133)
ABSTRACT
OBJECTIVE To quantify age-related variability of insulin needs during day and night closed-loop insulin delivery. RESEARCH DESIGN AND METHODS We retrospectively analyzed data from hybrid closed-loop studies involving young children (1–6 years old, n = 20), children (7–12 years, n = 21), adolescents (13–17 years, n = 15), and adults (>18 years, n = 58) with type 1 diabetes. The coefficient of variation quantified variability of insulin needs during 3 weeks of unrestricted-living hybrid closed-loop use. RESULTS Data from 2,365 nights and 2,367 days in 114 participants were analyzed. The coefficient of variation of insulin delivery was higher in young children compared with adults (mean difference at nighttime 10.7 percentage points [95% CI 2.9–18.4], P = 0.003; daytime 6.4 percentage points [95% CI 2.0–10.9], P = 0.002) and compared with adolescents (mean difference at nighttime 10.2 percentage points [95% CI 0.0–20.4], P = 0.049; daytime 7.0 percentage points [95% CI 1.1–12.8], P = 0.014). CONCLUSIONS Diabetes management in young children is complicated by higher variability in insulin requirements, supporting fast-track clinical practice adoption of closed-loop in this vulnerable population.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (12)
CITATIONS (68)